Europe — EMA
Opfolda (Miglustat)
Miglustat, the active ingredient in Opfolda, is an oral iminosugar presented as a tablet for oral use. It is used to treat certain rare metabolic disorders in pediatric and adult patients.
Request sourcing
What is Miglustat?
Miglustat, the active ingredient in Opfolda, is an oral iminosugar presented as a tablet for oral use. It is used to treat certain rare metabolic disorders in pediatric and adult patients. GNH USA supplies Opfolda as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Opfolda as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Miglustat used for?
Opfolda (miguel ??) is a substrate reduction therapy that targets the glycosphingolipid biosynthesis pathway. It is indicated for: - Niemann‑Pick disease type C: Provides the ...
What are the side effects of Miglustat?
Common ...
What precautions apply to Miglustat?
...
What does Miglustat interact with?
....
